The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

Andrew P. Hearn; Joanne Kavanagh; Grainne d'Ancona; Cris Roxas; Linda Green; Louise Thomson; Marianna Fernandes; Brian D. Kent; Jaideep Dhariwal; Alexanda M. Nanzer; David J. Jackson

doi:10.1016/j.jaip.2021.01.008

The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

Andrew P. Hearn, Joanne Kavanagh, Grainne d'Ancona, Cris Roxas, Linda Green, Louise Thomson, Marianna Fernandes, Brian D. Kent, Jaideep Dhariwal, Alexanda M. Nanzer, David J. Jackson^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

54 Citations (Scopus)

Original language	English
Pages (from-to)	2093-2096.e1
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	9
Issue number	5
DOIs	https://doi.org/10.1016/j.jaip.2021.01.008
Publication status	Published - May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaip.2021.01.008

Cite this

Hearn, A. P., Kavanagh, J., d'Ancona, G., Roxas, C., Green, L., Thomson, L., Fernandes, M., Kent, B. D., Dhariwal, J., Nanzer, A. M., & Jackson, D. J. (2021). The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma. Journal of Allergy and Clinical Immunology: In Practice, 9(5), 2093-2096.e1. https://doi.org/10.1016/j.jaip.2021.01.008

@article{9a767567b7a647fd83c1fb7d04ade90a,

title = "The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma",

author = "Hearn, {Andrew P.} and Joanne Kavanagh and Grainne d'Ancona and Cris Roxas and Linda Green and Louise Thomson and Marianna Fernandes and Kent, {Brian D.} and Jaideep Dhariwal and Nanzer, {Alexanda M.} and Jackson, {David J.}",

year = "2021",

month = may,

doi = "10.1016/j.jaip.2021.01.008",

language = "English",

volume = "9",

pages = "2093--2096.e1",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "5",

}

Hearn, AP , Kavanagh, J, d'Ancona, G, Roxas, C, Green, L, Thomson, L, Fernandes, M, Kent, BD, Dhariwal, J, Nanzer, AM & Jackson, DJ 2021, 'The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma', Journal of Allergy and Clinical Immunology: In Practice, vol. 9, no. 5, pp. 2093-2096.e1. https://doi.org/10.1016/j.jaip.2021.01.008

TY - JOUR

T1 - The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

AU - Hearn, Andrew P.

AU - Kavanagh, Joanne

AU - d'Ancona, Grainne

AU - Roxas, Cris

AU - Green, Linda

AU - Thomson, Louise

AU - Fernandes, Marianna

AU - Kent, Brian D.

AU - Dhariwal, Jaideep

AU - Nanzer, Alexanda M.

AU - Jackson, David J.

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85100746563&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2021.01.008

DO - 10.1016/j.jaip.2021.01.008

M3 - Article

C2 - 33486140

AN - SCOPUS:85100746563

SN - 2213-2198

VL - 9

SP - 2093-2096.e1

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 5

ER -

The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

UN SDGs

Access to Document

Other files and links

Cite this